HIF1A and renal cell carcinoma: HIF‐2α induction, by contrast, has been shown to counteract HIF‐1α‐dependent cell cycle arrest in renal cell carcinoma lines, thereby resulting in enhanced proliferation dependent on c‐Myc gain‐of‐function (Gordan et al, 2007).